I feel your risk of low blood sugar is actually lower when youre taking a GLP-1 because you eventually need less insulin. SGLT-2s increase the risk of DKA and dehydration The biggest challenge to using SGLT-2 inhibitors in type 1 diabetes is the risk for DKA, including a rare type called euglycemic DKA (EDKA)
But taking beta-blockers when you have diabetes may prevent you from experiencing some of these symptoms, including: tremors fast heartbeat sense of dread or anxiety This means that if you have low blood sugar while taking a beta-blocker, you may not notice these symptoms
Results aren't immediate, as it can take several weeks for the medication to have its full effect
They get meaningful results with minimal side effects, and more importantly, theyre building sustainable skills rather than just depending on medication
It may be too early to make material adjustments to those assumptions for AOMs, but they increase confidence in future mortality and morbidity improvements